At the time of initial diagnosis of advanced breast cancer—whether newly diagnosed or recurrent—it is recommended to perform a biopsy of the primary tumor or metastatic lesion to assess estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2) status (expert recommendation). The gene discussed is ERBB2; the disease is breast carcinoma.